| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,538 |
2,243 |
$121K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
524 |
460 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
77 |
73 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
16 |
16 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
26 |
26 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
35 |
30 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
366 |
166 |
$1K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
86 |
82 |
$481.90 |
| 90674 |
|
14 |
14 |
$336.70 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
91 |
89 |
$178.52 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14 |
14 |
$139.86 |
| 81002 |
|
14 |
14 |
$37.52 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
86 |
82 |
$33.24 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
39 |
37 |
$20.80 |
| 99072 |
|
35 |
35 |
$0.00 |
| 99000 |
|
42 |
42 |
$0.00 |